TacrolimusImmunosuppressionImmunosuppressive AgentsCyclosporineKidney TransplantationGraft RejectionMycophenolic AcidLiver TransplantationGraft SurvivalImmune ToleranceCalcineurinOintmentsTransplantation, HomologousAzathioprineAntilymphocyte SerumSirolimusPancreas TransplantationDrug Therapy, CombinationTreatment OutcomeAdrenal Cortex HormonesImmunocompromised HostHeart TransplantationTransplantation ImmunologyOrgan TransplantationTime FactorsIslets of Langerhans TransplantationTissue DonorsDrug MonitoringAdministration, TopicalLiving DonorsT-LymphocytesSteroidsRetrospective StudiesCytochrome P-450 CYP3AMethylprednisoloneTransplantationGraft vs Host DiseaseFollow-Up StudiesKidneyBiopsyPostoperative ComplicationsPrednisoneSpleenPrednisoloneLymphoproliferative DisordersDermatologic AgentsMuromonab-CD3Dose-Response Relationship, DrugLymphocyte ActivationAntibodies, MonoclonalTransplantation TolerancePolyomavirus InfectionsRecurrenceDrug InteractionsLung TransplantationLiver FailureEmollientsBone Marrow TransplantationProspective StudiesTransplantation ConditioningDermatitis, AtopicAntibodies, NeoplasmMice, Inbred BALB CErythemaTacrolimus Binding Protein 1ADrug Administration ScheduleT-Lymphocytes, RegulatoryRats, Inbred LewBK VirusMice, Inbred C57BLCreatinineAdministration, OralAcute DiseaseKidney DiseasesHistocompatibility TestingCyclosporinsUltraviolet RaysTransplantation ChimeraAntibodies, Monoclonal, HumanizedDermatitis, IrritantHematopoietic Stem Cell TransplantationSkin TransplantationKidney Function TestsInfectionOpportunistic InfectionsAntibody FormationTransplantsDermatitis, ContactSurvival RateImmunocompetenceLymphocytesCytomegalovirus InfectionsFacial TransplantationRisk FactorsLiver DiseasesHistocompatibilityCyclophosphamideGlucocorticoidsIncidenceHand Transplantation